Picture of 180 Life Sciences logo

ATNF 180 Life Sciences Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for 180 Life Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-0.091-10.9-20.3-38.7-19.9
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items-1.374.189.0724.711.3
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.0142.73-8.22.72-0.014
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-1.45-3.87-19.4-12.1-10.9
Capital Expenditures0
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items10814.50
Sale of Business
Sale of Fixed Assets
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities10814.50
Financing Cash Flow Items0.74-0.138-2.06-1.01-0.06
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-107-8.7325.410.95.91
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.2762.036.12-1.25-4.99